Cobra Biologics provides high-quality contract manufacturing services for the pharmaceutical industry, specialising in non-GMP, HQ, and GMP plasmid DNA manufacturing for preclinical and clinical supply. Founded in 1992, Cobra Biologics utilises a standard platform process encompassing plasmid transformation, high-density fermentation, alkaline cell lysis, chromatographic purification, and formulation. The company supports various stages of drug development, offering a comprehensive suite of services designed to meet the diverse needs of its clients.

Services include:
- Accelerated Stability Studies
- Analytical Services
- Assay Development
- Bioanalytical Services
- Biologics
- Process Development
- Bioprocess Validation
- Bioprocessing
- Biosimilars
- Cell Culture Media Development
- Clinical Trials
- Chemistry (CMC)
- Manufacturing
- Contract Development and Manufacturing (CDMO)
- Contract Manufacturing (CMO)
- Downstream Processing
- Drug Delivery Devices
- Drug Development
- Feasibility Studies
- Fermentation
- Filling
- Ampule
- Capsule
- Syringe
- Vials
- Formulation Development
- Auditing
- Chromatography
- In Vitro Testing
- Lyophilization
- APIs (Active Pharmaceutical Ingredients)
- Aseptic Fill-Finish
- Bioequivalence
- Clinical Trial Materials
- Dose Form
- Non-Sterile
- Generics
- Injectables
- Liquids
- Microbial-based Therapeutic Proteins
- Oral Drug Delivery
- Powders
- Sterile
- Proteins
- Solid Dosage
- Solutions & Suspensions
- Pre-filled
- Vaccines
- Parenterals
- Pilot-Scale Filling
- Process R&D
- Process Validation Studies
- Protein Extraction/Purification
- Purification
- Quality QA/QC
- R&D Services
- Scale-Up
- Stability Studies
- Stability
- ICH
- Sterile Filling
- Validation
- Virology

Cobra Biologics is committed to delivering high-quality, reliable manufacturing solutions to support the pharmaceutical industry's evolving needs. For more information, please visit cobrabio.com.